COMMONWEALTH EQUITY SERVICES, LLC - ANAVEX LIFE SCIENCES CORP ownership

ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 93 filers reported holding ANAVEX LIFE SCIENCES CORP in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of ANAVEX LIFE SCIENCES CORP
ValueSharesWeighting
Q3 2023$545
-23.8%
83,233
-5.4%
0.00%0.0%
Q2 2023$715
-4.9%
87,995
+0.3%
0.00%
-50.0%
Q1 2023$752
-10.7%
87,770
-3.6%
0.00%0.0%
Q4 2022$842
-99.9%
91,015
+10.5%
0.00%0.0%
Q3 2022$850,000
+3.5%
82,375
+0.3%
0.00%0.0%
Q2 2022$821,000
-16.4%
82,090
+2.8%
0.00%0.0%
Q1 2022$982,000
-23.9%
79,840
+7.3%
0.00%
-33.3%
Q4 2021$1,290,000
+70.0%
74,424
+75.9%
0.00%
+50.0%
Q3 2021$759,000
-20.4%
42,315
+1.3%
0.00%0.0%
Q2 2021$954,000
+70.7%
41,769
+11.6%
0.00%0.0%
Q1 2021$559,000
+135.9%
37,429
-15.0%
0.00%
+100.0%
Q4 2020$237,000
+62.3%
44,050
+36.7%
0.00%
Q3 2020$146,000
-6.4%
32,230
+1.4%
0.00%
-100.0%
Q2 2020$156,000
+54.5%
31,777
-0.9%
0.00%
Q1 2020$101,000
+31.2%
32,077
+7.0%
0.00%
Q4 2019$77,000
-13.5%
29,977
+6.4%
0.00%
Q3 2019$89,000
+20.3%
28,185
+28.0%
0.00%
Q2 2019$74,000
+19.4%
22,028
+7.4%
0.00%
Q1 2019$62,000
+93.8%
20,513
-1.0%
0.00%
Q4 2018$32,000
-20.0%
20,713
+39.8%
0.00%
Q3 2018$40,000
+17.6%
14,820
+15.6%
0.00%
Q2 2018$34,000
+3.0%
12,820
+5.3%
0.00%
Q1 2018$33,000
-2.9%
12,170
+16.2%
0.00%
Q4 2017$34,00010,4750.00%
Other shareholders
ANAVEX LIFE SCIENCES CORP shareholders Q4 2020
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 942,500$9,727,0003.29%
Pier Capital, LLC 384,811$3,971,0000.68%
AllSquare Wealth Management LLC 65,956$681,0000.49%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$1,032,0000.35%
Royal Capital Wealth Management, LLC 18,500$191,0000.22%
Bridgefront Capital, LLC 10,214$105,0000.11%
Hikari Power Ltd 85,585$883,0000.10%
Orion Capital Management LLC 9,500$98,0000.08%
OCCUDO QUANTITATIVE STRATEGIES LP 86,158$889,0000.07%
Hennion & Walsh Asset Management, Inc. 66,459$686,0000.04%
View complete list of ANAVEX LIFE SCIENCES CORP shareholders